Article

Multiple regions within 8q24 independently affect risk for prostate cancer

Harvard University, Cambridge, Massachusetts, United States
Nature Genetics (Impact Factor: 29.65). 05/2007; 39(5):638-44. DOI: 10.1038/ng2015
Source: PubMed

ABSTRACT After the recent discovery that common genetic variation in 8q24 influences inherited risk of prostate cancer, we genotyped 2,973 SNPs in up to 7,518 men with and without prostate cancer from five populations. We identified seven risk variants, five of them previously undescribed, spanning 430 kb and each independently predicting risk for prostate cancer (P = 7.9 x 10(-19) for the strongest association, and P < 1.5 x 10(-4) for five of the variants, after controlling for each of the others). The variants define common genotypes that span a more than fivefold range of susceptibility to cancer in some populations. None of the prostate cancer risk variants aligns to a known gene or alters the coding sequence of an encoded protein.

Download full-text

Full-text

Available from: Daniel O Stram, Jul 07, 2015
0 Followers
 · 
196 Views
  • Source
    • "First identified SNPs associated with PCa risk were located within the 8q24 chromosomal region [8-10]. Afterwards, a large number of other PCa risk loci were identified, many of which were replicated in different populations [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [34] [35] [36]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent study, which included meta-analysis of two genome-wide association studies (GWAS), followed by a replication, identified the association between single nucleotide polymorphism (SNP) rs3787016 at 19p13 and prostate cancer (PCa) risk. Considering possible genetic differences between populations, we conducted the study in order to evaluate the association of this polymorphism with prostate cancer risk in Serbian population. 261 samples of peripheral blood were obtained from the patients with PCa and 257 samples from patients with benign prostatic hyperplasia (BPH). 106 volunteers who gave samples of bucal swabs comprised the control group. For individuals diagnosed with PCa clinicopathological characteristics including serum prostate-specific antigen (PSA) level at diagnosis, Gleason score (GS) and clinical stage were determined. Genotypization of rs3787016 was performed by using Taqman(®) SNP Genotyping Assay. The differences in alelle and genotype frequencies between analyzed groups of subjects were performed by using PLINK, SPSS 17.0 for Windows and SNPStats statistical software. No significant association of rs3787016 with PCa risk was determined comparing allele and genotype frequencies among group of patients diagnosed with PCa and the control group, as well as among groups of patients with PCa and BPH. Also, no evidence of association of rs3787016 with PCa risk was shown using tests for association under dominant and recessive genetic models. SNP rs3787016 showed no significant association with standard prognostic parameters regarding PCa progression, nor with the risk of disease progression assessed according to two different risk classification systems.
    International Journal of Clinical and Experimental Medicine 01/2013; 6(1):57-66. · 1.42 Impact Factor
  • Source
    • "At least three distinct loci in separate linkage disequilibrium blocks are present on 8q24, all of which have been confirmed in subsequent genome-wide association studies (Gudmundsson et al, 2007; Yeager et al, 2007; Eeles et al, 2008; Thomas et al, 2008). Analyses by Haiman et al identified at least seven or more independent risk alleles in these blocks (Haiman et al, 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: It is recognised that the risk of prostate cancer is higher in black men than in white men worldwide. Recent studies suggest that a number of genetic mutations in black men predispose them to this disease; hence, race as well as environmental factors such as diet and migration are thought to be the determining factors. This review compares data from the United States (US), which suggest that African-American men have a 60% higher risk for developing prostate cancer with poorer prognosis in comparison with their white counterparts, with similar studies carried out in the United Kingdom (UK) and also in African and Caribbean countries. Studies from the United States and the United Kingdom came to significantly different conclusions, and this has implications for policy development, awareness raising among black men in each country and clinical practice.
    British Journal of Cancer 08/2011; 105(4):481-5. DOI:10.1038/bjc.2011.273 · 4.82 Impact Factor
  • Source
    • "Recent studies have identified numerous single nucleotide polymorphisms (SNPs) that modify an individual's risk of developing prostate cancer (Amundadottir et al, 2006; Eeles et al, 2008; Gudmundsson et al, 2007a; Gudmundsson et al, 2008; Gudmundsson et al, 2007b; Haiman et al, 2007; Robbins et al, 2007; Thomas et al, 2008). Although some investigators have considered the possibility of heterogeneity between ethnic groups, where a SNP shows a different effect on prostate cancer risk depending on the population being studied, these studies only considered ethnic groups with different continents of ancestral origins (Haiman et al, 2007; Waters et al, 2009; Yamada et al, 2009; Hooker et al, 2010; Zheng et al, 2010). As alleles of numerous SNPs are known to vary in frequency across Europe (Bersaglieri et al, 2004), and population substructure is consistently observed in Americans with ancestry from different locations in Europe (Price et al, 2008; Tian et al, 2008), there is a possibility that prostate cancer risk alleles may have different effects in different populations of European ancestry. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recently, numerous prostate cancer risk loci have been identified, some of which show association in specific populations. No study has yet investigated whether these single nucleotide polymorphisms (SNPs) are associated with prostate cancer in the Ashkenazi Jewish (AJ) population. A total of 29 known prostate cancer risk SNPs were genotyped in 963 prostate cancer cases and 613 controls of AJ ancestry. These data were combined with data from 1241 additional Ashkenazi controls and tested for association with prostate cancer. Correction for multiple testing was performed using the false discovery rate procedure. Ten of twenty-three SNPs that passed quality control procedures were associated with prostate cancer risk at a false discovery rate of 5%. Of these, nine were originally discovered in studies of individuals of European ancestry. Based on power calculations, the number of significant associations observed is not surprising. We see no convincing evidence that the genetic architecture of prostate cancer in the AJ population is substantively different from that observed in other populations of European ancestry.
    British Journal of Cancer 08/2011; 105(6):864-9. DOI:10.1038/bjc.2011.307 · 4.82 Impact Factor